Germany· DE-A57-22a12230c167c1b3
Amofin
A amorolfine product containing amorolfine, registered in Germany by Galenpharma Gmbh. The same ATC class is registered in 15 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Amorolfine is registered in 15 of 19 countries.
Countries holding a registration under ATC D01AE16 (amorolfine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Amorolfine · ATC D01AE16
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Amorolfine
- Manufacturer
- Galenpharma Gmbh
- Country
- Germany (DE)
- ATC code
- D01AE16
- ATC class
- Amorolfine
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amorolfine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAmorolfine 5% medicated nail lacquerZentiva Pharma UK Ltd
- FranceAMOROLFINE ARROW 5 %, vernis à ongles médicamenteuxARROW GENERIQUES
- SwitzerlandAmorolfin Leman Nagellack
- SpainAMOROLFINA BLUEFISH 50 MG/ML BARNIZ DE UÑAS MEDICAMENTOSOBluefish Pharmaceuticals Ab (Publ)
- BelgiumAmorolfine Oystershell 50 mg/mlOystershell
- CzechiaAMOROLFIN BELUPOBelupo, s.r.o., Bratislava
- FinlandAmorolfin ratiopharmratiopharm GmbH
- PolandAmorolakSun-Farm Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Amorocutan, Amorolfin Laboratoires Gerda
- Belgium · Amorolfine Schollmedical, Amorolfine Teva
- Bulgaria · Екзодерил, Фунгитер
- Cyprus · Loceryl
- Czechia · Amorolfin Belupo, Exorolak
- Denmark · Finail, Loceryl
- Estonia · Exolorfin, Loceryl
- Spain · Amorolfina, Amorolfina Bluefish
- Finland · Loceryl
- France · Amorolfine Arrow, Amorolfine Bgr
- United Kingdom (Northern Ireland) · Amorolfine Accord-Uk, Amorolfine Aspire Pharma
- Greece · Loceryl, Schollmed Fungal Nail
- Croatia · Amofin, Arivil
- Hungary · Amolak, Amolak Rx
- Ireland · Amorolfine Bluefish, Amorolfine Rowex
- Iceland · Amorolfin Alvogen, Amorolfin Apofri
- Italy · Amorolfina, Amorolfina Mylan Generics
- Lithuania · Funtrol, Gifugan
- Luxembourg · Loceryl
- Latvia · Exolorfin, Loceryl
- Malta · Loceryl
- Norway · Loceryl
- Poland · Amorolak, Funtrol
- Portugal · Amorolfina Bluefish, Amorolfina Bluepharma
- Romania · Exoderil Set
- Sweden · Amorolfin Abece, Amorolfin Apofri
- Slovenia · Bemofin, Exolorfin
- Slovakia · Amorolfín Belupo, Exorolfin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/33d10874-c29b-4da1-ae2e-d0eda7ecc7e7 GET /v1/drugs/33d10874-c29b-4da1-ae2e-d0eda7ecc7e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Amorolfine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about amorolfine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.